EPIS® Právní systém | Plné znění

XXŘ&Xxxxxx;XXX&Xxxxxx; KOMISE (EU) 2016/1179

xx dne 19. čxxxxxxx 2016,

xxxx&xxxxxx;x se xxx účely přizpůsobení xěxxxxxxxxxxxxx&xxxxxx;xx xxxxxxx xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx xxx EHP)

XXXXXXX&Xxxxxx; XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; xxxx,

s ohledem xx xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (ES) č.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě a zrušení xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx na čl. 37 xxxx.&xxxx;5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

vzhledem x&xxxx;xěxxx xůxxxůx:

(1)

Část 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 obsahuje xxx xxxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 xx uveden xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;č&xxxxxx;xxxxx 2 až 5 xř&xxxxxx;xxxx I nařízení (XX) č. 1272/2008. X&xxxx;xxxxxxx 3.2 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;xř&xxxxxx;xxxx XX xxěxxxxx Xxxx 67/548/XXX (2).

(2)

Xxxxxxxx x&xxxx;xxxx, žx směrnice 67/548/XXX xxxx x&xxxx;&xxxxxx;čxxxxx xx 1. června 2015 xxx&xxxxxx;xxx, xěxx xx x&xxxxxx;x xxx&xxxxxx;xxx i tabulka 3.2 x&xxxx;xř&xxxxxx;xxxx XX č&xxxxxx;xxx 3. Aby xx x&xxxxxx;xx xxxxxxxx přechod x&xxxx;xxx&xxxxxx;xx uplatňování xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxěxx xx xxxxxx&xxxxxx; xxx&xxxxxx;xx&xxxxxx; xxx&xxxxxx;x účinku xř&xxxxxx;xx xxž 1.&xxxx;čxxxxx&xxxx;2017.

(3)

Evropské xxxxxxřx xxx xxxxxxx&xxxxxx; látky (XXXX) xxxx x&xxxx;xxxxxxx x&xxxx;čx&xxxxxx;xxxx&xxxx;37 xxř&xxxxxx;xxx&xxxxxx; (ES) č.&xxxx;1272/2008 xřxxxxžxxx x&xxxxxx;xxxx xx xxx&xxxxxx;, xxxxxxxxxxxx&xxxxxx; xxxx zrušené xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx a označení xěxxxx&xxxxxx;xx x&xxxxxx;xxx. Xx x&xxxxxx;xxxxě xxxxxxxxxx k těmto x&xxxxxx;xxxůx, xxxx&xxxxxx; vydal X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; xxxxx (XXX) působící v rámci Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; látky, xxxxž x&xxxx;xřxxxx&xxxxxx;xxx zúčastněných xxxxx, xx xxxxx&xxxxxx; xxx&xxxxxx;xx, xxxxxxxxxxxx či xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx látek.

(4)

Pokud xxx x&xxxx;x&xxxxxx;xxx &xxxxx;xxxxx&xxxxx;, XXX xxxxxxxx xx xx&xxxxxx;x xěxxxx&xxxxxx;x xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2013 klasifikovat xx xxxx xxxxxxxx xxx reprodukci xxxxxxxxx 1&xxxx;X. Avšak vzhledem x&xxxx;xxxx, žx xxxxxxxxxx xxxxxxx xxxxxxě biologické xxxxxxxxxxx xxxxx v celistvé xxxxě, je xřxxx xxxxx&xxxxxx;xxxx xxxx xxxxxxxxx xxxxxx (xxxxxxxx č&xxxxxx;xxxx xěx&xxxxxx;&xxxxxx; xxxx xxxxx 1&xxxx;xx) a práškovou xxxxxx (xxxxxxxx č&xxxxxx;xxxx xxx&xxxxxx;&xxxxxx; xxž 1&xxxx;xx). Je xxxxx xxxxx&xxxxxx;, xxx xxx xxxxxxx xxxxxxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; xxxxx (XXX) &xx;&xxxx;0,03 % xxx xx&xxxxxx;&xxxxxx;xxxxx xxxxx x&xxxx;xxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; limit (GCL) &xx;&xxxx;0,3 % pro xxxxxxxxx xxxxx.

(5)

Pokud xxx x&xxxx;x&xxxxxx;xxx xxxxxxx&xxxxxx;x&xxxxxx; měď, xěxx xx být xx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; č.&xxxx;1272/2008 zařazena xxxxxxxxxxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxx doporučená xx xxxxxxxxx&xxxxxx;xx XXX xx dne 4.&xxxx;xxxxxxxx&xxxx;2014, xxxxxxž jsou k dispozici xxxxxxxčx&xxxxxx; xěxxxx&xxxxxx; xůxxxx xxůxxxňxx&xxxxxx;x&xxxxxx; xxxx novou xxxxxxxxxxx. Xxxxxxxxx&xxxxxx; xxxxxxxxxxčx&xxxxxx; xxxxxxx pro xxxxxxxxxxx xxxxxxxčxxxx xxx xxxx&xxxxxx; xxxxxřxx&xxxxxx; by však xxxxxxxx x&xxxxxx;x neměly, xxxxť xxžxxxx&xxxxxx; xxx&xxxxxx;&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx XXX xxxxxxxx x&xxxx;xěxxxx&xxxxxx;x &xxxxxx;xxxůx x&xxxx;xxxxxxxě xxx xxxx&xxxxxx; xxxxxřxx&xxxxxx; prezentovaným xx xxxxxx xxxěxx&xxxxxx; poté, xx bylo xxxxxxxxxx x&xxxxxx;xxxx XXX xřxx&xxxxxx;xx Xxxxxx.

(6)	Xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xx proto xěxx x&xxxxxx;x odpovídajícím xxůxxxxx xxěxěxx.

(7)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; xx xxxěxx x&xxxxxx;x požadováno xxxxx, xxxxxxž dodavatelé xxxxx xxxřxxxxxx xxčxx&xxxxxx; čxxxx&xxxxxx; xxxxx&xxxxxx; xx xx, xxx xřxxxůxxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x x&xxxx;xxxxxxx xx&xxxxxx;xxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxx xxxxx&xxxxxx; xxxx xxxxěž xxxx&xxxxxx; k tomu, aby xx dodavatelé xxxxx xřxxxůxxxxx xxx&xxxxxx;&xxxxxx;x xxxxxxxxxxx&xxxxxx;x xxxxxxxxxxx, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxř. xxxxxxxxxxx xxxxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;22 x&xxxxxx;xx. x) xxxx v článku 23 xxř&xxxxxx;xxx&xxxxxx; Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1907/2006 (3), x&xxxx;čx&xxxxxx;xxx&xxxx;50 nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;528/2012 (4) xxxx x&xxxx;čx&xxxxxx;xxx&xxxx;44 xxř&xxxxxx;xxx&xxxxxx; Evropského parlamentu x&xxxx;Xxxx (ES) č.&xxxx;1107/2009 (5), x&xxxx;xxx je xxxxx xxxxxx.

(8)

X&xxxx;xxxxxxx x&xxxx;xřxxxxxx&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxx&xxxxxx; xxxžňxx&xxxxxx; xxxxxxxxxě xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxx&xxxxxx; xř&xxxxxx;xx, by xxxxxxxxx&xxxxxx; xěxx x&xxxxxx;x xxžxxxx xxxž&xxxxxx;x nové xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx a odpovídajícím xxůxxxxx xxxxxxxxxě xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; xřxx xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(9)	Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x xxxx x&xxxx;xxxxxxx se xxxxxxxxxxx x&xxxxxx;xxxx zřízeného čx&xxxxxx;xxxx&xxxx;133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX XXXX NAŘÍZENÍ:

Čx&xxxxxx;xxx&xxxx;1

Xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx mění takto:

1)	Xř&xxxxxx;xxxx XX xx xěx&xxxxxx; x&xxxx;xxxxxxx s přílohou xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

2)	X&xxxx;xř&xxxxxx;xxxx VI xx xxx&xxxxxx;xxx xxxxxxx 3.2.

Čx&xxxxxx;xxx&xxxx;2

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; unie.

2.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xx xxxžxxx xx 1. xřxxxx 2018.

Xxxxxxxxx&xxxxxx; čx.&xxxx;1 xxxx.&xxxx;2 xx xxxžxxx xx 1.&xxxx;čxxxxx&xxxx;2017.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxě od xxxxxxxx 2 xxxxx x&xxxxxx;x x&xxxxxx;xxx a směsi před xxxx 1. března 2018 xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x&xxxx;xxxxxx x&xxxx;xxxxxxx s nařízením (XX) č.&xxxx;1272/2008 ve xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

Xxxx nařízení je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx státech.

V Bruselu xxx 19. července 2016.

Xx Komisi

předseda

Jean-Claude XXXXXXX

(1)&xxxx;&xxxx;Xx. věst. X&xxxx;353, 31.12.2008, s. 1.

(2)&xxxx;&xxxx;Xxxxxxxx Xxxx 67/548/XXX xx xxx 27.&xxxx;xxxxxx&xxxx;1967 x&xxxx;xxxxxxxxxx xxxxxxxx a správních xxxxxxxx xxxxxxxxxx se xxxxxxxxxxx, balení x&xxxx;xxxxxxxxxx xxxxxxxxxxxx xxxxx (Xx. xxxx. 196, 16.8.1967, x.&xxxx;1).

(3) Nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1907/2006 xx dne 18. prosince 2006 x&xxxx;xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx látek, x&xxxx;xxxxxxx Evropské agentury xxx chemické xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/ES x&xxxx;x&xxxx;xxxxxxx nařízení Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (ES) č. 1488/94 x&xxxx;xxxxxxxx Rady 76/769/XXX, Xx. věst. X&xxxx;396, 30.12.2006, x.&xxxx;1.

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;528/2012 xx xxx 22.&xxxx;xxxxxx&xxxx;2012 x&xxxx;xxxxxxxx biocidních xxxxxxxxx xx trh x&xxxx;xxxxxx xxxxxxxxx (Úř. věst. X&xxxx;167, 27.6.2012, x.&xxxx;1).

(5) Nařízení Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1107/2009 xx xxx 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx přípravků xx xxxxxxx xxxxxxx na xxx x&xxxx;x&xxxx;xxxxxxx xxxxxxx Xxxx 79/117/XXX a 91/414/EHS (Xx. xxxx. X&xxxx;309, 24.11.2009, x.&xxxx;1).

XXXXXXX

Xxxxxxx 3.1, xxxxx 3, přílohy XX, xxxxxxxx (XX) x.&xxxx;1272/2008 xx mění takto:

a)	položky xxxxxxxxxxxx xxxxxxxxx xxxxxx 607-331-00-5 a 609-066-00-0 xx xxxxxxx;

xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 x&xxxx;616-207-00-X xx xxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
„006-035-00-8	xxxxxxxxxx (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl xxxxxxxxxxxxxxxx	245-430-1	23103-98-2	Xxxx. 2 Acute Xxx. 3 Xxxxx Tox. 3 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X351 X331 X301 X317 X400 X410	XXX08 XXX06 XXX09 Xxx	X351 X331 X301 X317 X410		X&xxxx;= 10 M = 100“
„029-002-00-X	xxxx xxxxx	215-270-7	1317-39-1	Xxxxx Xxx. 4 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X332 X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X302 X318 X410		X&xxxx;= 100“
„602-020-00-0	1,2-dichlorpropan; propylendichlorid	201-152-2	78-87-5	Flam. Xxx. 2 Carc. 1B Acute Xxx. 4* Acute Tox. 4*	X225 X350 X332 X302	XXX02 XXX08 XXX07 Xxx	X225 X350 X332 X302“
„602-033-00-1	xxxxxxxxxxx	203-628-5	108-90-7	Xxxx. Liq. 3 Xxxxx Xxx. 4 Xxxx Xxxxx. 2 Xxxxxxx Xxxxxxx 2	X226 X332 X315 X411	XXX02 XXX07 XXX09 Xxx	X226 X332 X315 X411“
„603-055-00-4	xxxxxxxxxxxx; 1,2-xxxxxxxxxxx; xxxxxxxxxxxx	200-879-2	75-56-9	Xxxx. Xxx. 1 Carc. 1X Xxxx. 1X Xxxxx Tox. 3 Xxxxx Xxx. 3 Xxxxx Xxx. 4 XXXX XX 3 Xxx Xxxxx. 2	X224 X350 X340 X331 X311 X302 X335 X319	XXX02 XXX08 XXX06 Xxx	X224 X350 X340 X331 X311 X302 X335 X319“
„604-030-00-0	xxxxxxxx X; 4,4′-xxxxxxxxxxxxxxxxxxxx	201-245-8	80-05-7	Xxxx. 1X XXXX SE 3 Xxx Xxx. 1 Skin Xxxx. 1	X360X X335 X318 X317	XXX08 XXX05 GHS07 Dgr	H360F H335 H318 H317“
„604-092-00-9	dodecylfenol, xxxxxxxxxx; [1] 2-xxxxxxxxxxxx, rozvětvený; [2] 3-xxxxxxxxxxxx, xxxxxxxxxx; [3] 4-xxxxxxxxxxxx, xxxxxxxxxx; [4] xxxxxxxx tetrapropenylfenolu [5]	310-154-3 [1] [2] [3] [4] [5]	121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5]	Xxxx. 1X Xxxx Xxxx. 1C Eye Dam. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H360F H314 H318 H400 H410	GHS08 GHS05 GHS09 Dgr	H360F H314 H410		M = 10 X&xxxx;= 10“
„605-013-00-0	chloralosa (XXX); (X)-1,2-X-(2,2,2-xxxxxxxxxxxxxxxxx)-α-X-xxxxxxxxxxxxx; xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxx	240-016-7	15879-93-3	Xxxxx Xxx. 4* Xxxxx Tox. 3 XXXX XX 3 Aquatic Xxxxx 1 Xxxxxxx Chronic 1	X332 X301 X336 X400 X410	XXX06 XXX09 Xxx	X332 X301 X336 X410		X&xxxx;= 10 X&xxxx;= 10	C“
„605-022-00-X	glutaral; xxxxxxxxxxxxx; 1,5-xxxxxxxxxx	203-856-5	111-30-8	Xxxxx Xxx. 2 Acute Xxx. 3 XXXX SE 3 Xxxx Xxxx. 1X Xxxx. Sens. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 2	X330 X301 X335 X314 X334 X317 X400 X411	XXX06 XXX05 XXX08 XXX09 Xxx	X330 X301 X335 X314 X334 X317 X410	XXX071	XXXX XX 3; X335: 0,5 % ≤ X < 5 % X&xxxx;= 1“
„606-014-00-9	xxxxxxxxxxxx (ISO); 2-[2-(4-chlorfenyl)-2-fenylacetyl]indan-1,3-dion	223-003-0	3691-35-8	Repr. 1X Xxxxx Xxx. 1 Acute Xxx. 1 Xxxxx Xxx. 1 XXXX RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): C ≥&xxxx;0,1 % XXXX XX 2; H373 (krev): 0,01 % ≤ X &xx;&xxxx;0,1 % X&xxxx;= 1 X&xxxx;= 1“
„606-021-00-7	X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx	212-828-1	872-50-4	Xxxx. 1X XXXX XX 3 Skin Xxxxx. 2 Xxx Irrit. 2	X360X*** X335 X315 X319	XXX08 XXX07 Xxx	X360X*** X335 X315 X319		XXXX XX 3; X335: X ≥&xxxx;10 %“
„607-056-00-0	warfarin (XXX); 4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [1] (S)-4-hydroxy-3-(1-fenyl-3-oxobutyl)-2H-chromen-2-on; [2] (X)-4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [3]	201-377-6 [1] 226-907-3 [2] 226-908-9 [3]	81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]	Xxxx. 1&xxxx;X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 2 STOT XX 1 Xxxxxxx Xxxxxxx 2	X360X X330 X310 X300 X372 (xxxx) X411	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (krev) H411		Repr. 1&xxxx;X; H360D: C ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,5 % XXXX RE 2; X373 (krev): 0,05 % ≤ X &xx;&xxxx;0,5 %“
„607-059-00-7	xxxxxxxxxxxx (XXX); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naftyl)-2H-chromen-2-on	227-424-0	5836-29-3	Repr. 1B Acute Xxx. 2 Xxxxx Xxx. 3 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxxxx 1	X360X X330 X311 X300 X372 (xxxx) X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X311 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: C ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥ 1,0 % XXXX XX 2; X373 (xxxx) 0,1 % ≤ X &xx;&xxxx;1,0 % X&xxxx;= 10“
„607-157-00-X	xxxxxxxxx (ISO); 3-[3-(xxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-978-4	56073-07-5	Xxxx. 1X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,02 % XXXX XX 2; X373 (xxxx): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 M = 10“
„607-172-00-1	brodifakum (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-980-5	56073-10-0	Xxxx. 1&xxxx;X Xxxxx Tox. 1 Xxxxx Xxx. 1 Acute Xxx. 1 XXXX RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1&xxxx;X; X360X: X ≥&xxxx;0,003 % XXXX RE 1; H372 (krev): X ≥ 0,02 % XXXX XX 2; X373 (xxxx): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 M = 10“
„607-375-00-5	flokumafen (XXX); reakční xxxx xxx-4-xxxxxxx-3-[3-(4{[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx a trans-4-hydroxy-3-[3-(4{[4-(trifluormethyl)benzyl]oxy}fenyl)-1,2,3,4-tetrahydro-1-naftyl]-2H-chromen-2-on	421-960-0	90035-08-8	Repr. 1X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 STOT XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1B; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,05 % XXXX XX 2; X373 (xxxx): 0,005 % ≤ X &xx;&xxxx;0,05 % X&xxxx;= 10 M = 10“
„607-623-00-2	xxxxxxxxxx-xxxxxx	201-553-2	84-69-5	Xxxx. 1X	X360Xx	XXX08 Xxx	X360Xx“
„613-166-00-X	xxxxxxxxxxx (ISO); 7-fluor-4-(prop-2-yn-1-yl)-6-(3,4,5,6-tetrahydroftalimido)-1,4-benzoxazin-3(2H)-on	—	103361-09-7	Repr. 1B Aquatic Xxxxx 1 Xxxxxxx Chronic 1	X360X X400 X410	XXX08 XXX09 Xxx	X360X X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 1 000 “
„613-121-00-4	xxxxxxxxxxxxx (ISO); 1-(2-chlorbenzensulfonyl)-3-(4,6-dimethyl-1,3,5-triazin-2-yl)močovina	265-268-5	64902-72-3	Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-011-00-4	N,N-dimethylacetamid	204-826-4	127-19-5	Repr. 1X Xxxxx Xxx. 4* Xxxxx Xxx. 4*	H360D*** H332 H312	GHS08 GHS07 Dgr	H360D*** H332 H312“
„616-037-00-6	acetochlor (ISO); X-(xxxxxxxxxxxx)-X-(2-xxxxx-6-xxxxxxxxxxx)-2-xxxxxxxxxxxxx	251-899-3	34256-82-1	Xxxx. 2 Repr. 2 Xxxxx Xxx. 4 STOT XX 3 XXXX XX 2 Xxxx Xxxxx. 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X351 X361x X332 X335 X373 (ledviny) H315 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H351 H361f H332 H335 H373 (xxxxxxx) X315 X317 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-207-00-X	xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx; XXXX	—	32289-58-0 27083-27-8	Xxxx. 2 Xxxxx Xxx. 2 Acute Xxx. 4 XXXX RE 1 Xxx Dam. 1 Skin Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X351 X330 X302 X372 (xxxxxxx xxxxx) (xxxxxxxxx) X318 X317 X400 X410	XXX08 XXX06 XXX05 XXX09 Xxx	X351 X330 X302 X372 (xxxxxxx xxxxx) (vdechnutí) H318 H317 H410		M = 10 X&xxxx;= 10“

X&xxxx;xxxxxxx s posloupností xxxxxxxxxx xxxxx xx xxxxxxxx xxxx xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx chemických xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, multiplikační xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx chemických xxxxx	Xxxxx ES	Číslo XXX	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx slov	Kódy xxxxxxxxxxxx xxx o nebezpečnosti	Kódy doplň. xxxxxxxxxxxx vět o nebezpečnosti	Xxxxxxxxxx xxxxxxx. xxxxxx, multiplikační xxxxxxx	Xxxx.
„005-020-00-3	oktaboritan xxxxxxx, bezvodý; [1] oktaboritan xxxxxxx xxxxxxxxxxx [2]	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„014-046-00-4	xxxxxxxxxxx E-skla xxxxxxxxxxxxxxxxx xxxxxxx; [vápenato-hlinito-křemičitá xxxxxx s náhodnou xxxxxxxxx x&xxxx;xxxxx xxxxxxxxxxxxxxxx složením (x&xxxx;% xxxxxxxxxxxx): XxX2&xxxx;50,0-56,0 %, Xx2X3&xxxx;13,0-16,0 %, X2X3&xxxx;5,8-10,0 %, Xx2X &xx;&xxxx;0,6 %, X2X &xx;&xxxx;0,4 %, XxX 15,0-24,0 %, XxX &xx;&xxxx;5,5 %, Fe2O3 &xx;&xxxx;0,5 %, X2 &xx;&xxxx;1,0 %. Proces: xxxxxxx xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx a rotačním xxxxxxxx. (Xxxxx xxxxxxxxxx xxxxx xxxxx xxx xxxxxxxx x&xxxx;xxxxxxx koncentracích; xxxxxx xxxxxxx nevylučuje xxxxxxx).]	—	—	Xxxx. 1X	X350x	XXX08 Xxx	X350x			X“
„014-047-00-X	xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx; [vápenato-hlinito-křemičitá xxxxxx x&xxxx;xxxxxxxx orientací x&xxxx;xxxxx xxxxxxxx (v % xxxxxxxxxxxx): XxX2&xxxx;55,0-60,0 %, Xx2X3&xxxx;4,0-7,0 %, X2X3&xxxx;8,0-11,0 %, XxX2&xxxx;0,0-4,0 %, Xx2X 9,5-13,5 %, X2X 0,0-4,0 %, XxX 1,0-5,0 %, XxX 0,0-2,0 %, Xx2X3 &xx;&xxxx;0,2 %, XxX 2,0-5,0 %, XxX 3,0-6,0 %, X2 &xx;&xxxx;1,0 %. Xxxxxx: xxxxxxx jsou xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx procesem. (Xxxxx xxxxxxxxxx prvky xxxxx xxx přítomny x&xxxx;xxxxxxx xxxxxxxxxxxxx; seznam xxxxxxx xxxxxxxxxx xxxxxxx).]	—	—	Xxxx. 2	H351 (xxxxxxxxx)	XXX08 Xxx	X351 (xxxxxxxxx)			X“
„029-015-00-0	xxxxxxxxxxxx měďný	214-183-1	1111-67-7	Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410	XXX032	X&xxxx;= 10“
„029-016-00-6	oxid xxxxxxx	215-269-1	1317-38-0	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 100“
„029-017-00-1	xxxxxxx-xxxxxxxxxxx xxxxxxxxx	215-572-9	1332-65-6	Xxxxx Xxx. 4 Acute Xxx. 3 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	H332 H301 H400 H410	GHS06 GHS09 Dgr	H332 H301 H410		M = 10“
„029-018-00-7	xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx; [1] xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx xxxxxx [2]	215-582-3 [1] 215-582-3 [2]	1333-22-8 [1] 12527-76-3 [2]	Xxxxx Tox. 4 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	H302 H400 H410	GHS07 GHS09 Wng	H302 H410		M = 10“
„029-019-01-X	měděné xxxxxx (xxxxxxxx xxxxxxxxxxx xxxxxxxxx)	—	—	Xxxxx Xxx. 3 Xxxxx Xxx. 4 Xxx Irrit. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X331 X302 X319 X400 X410	XXX06 XXX09 Xxx	X331 X302 X319 X410		X&xxxx;= 10“
„029-020-00-8	xxxxxxxxx xxxxxxx – xxxxxxxx xxxxxxx (1:1)	235-113-6	12069-69-1	Xxxxx Tox. 4 Xxxxx Tox. 4 Eye Xxxxx. 2 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	H332 H302 H319 H400 H410	GHS07 GHS09 Wng	H332 H302 H319 H410		M = 10“
„029-021-00-3	xxxxxxxx měďnatý	243-815-9	20427-59-2	Acute Xxx. 2 Xxxxx Tox. 4 Xxx Xxx. 1 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	X330 X302 X318 X400 X410	XXX06 XXX05 XXX09 Xxx	X330 X302 X318 X410		X&xxxx;= 10“
„029-022-00-9	xxxxxxxxxxx jícha; reakční xxxxxxxx xxxxxx xxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx	—	8011-63-0	Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H332 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H332 H318 H410		M = 10“
„029-023-00-4	xxxxx xxxxxxx, pentahydrát	231-847-6	7758-99-8	Acute Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H302 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H302 H318 H410		M = 10“
„082-013-00-1	xxxxxxx xxxxxx; [xxxxxx xxxxxx &xx;&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362		Xxxx. 1 A; X360X: X ≥ 0,03 %“
„082-014-00-7	celistvé xxxxx: [xxxxxx xxxxxx ≥&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362“
„605-040-00-8	xxxxxxxxxxxxxxx-3-xxxxxxxxxx-xxxxxxxxxxxxx (XXXX); xxxxxxx xxxx 4-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehydu x&xxxx;3-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxxx; [1] 4-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx; [2] 3-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehyd [3]	- [1] 250-863-4 [2] 257-187-9 [3]	130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3]	Xxxx Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317“
„607-716-00-8	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-3-xxxxxxx-1-xxxxxxxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	249-205-9	28772-56-7	Xxxx. 1B Acute Xxx. 1 Xxxxx Tox. 1 Xxxxx Xxx. 1 XXXX RE 1 Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1B; X360X: X ≥&xxxx;0,003 % XXXX RE 1; X372 (krev): X ≥&xxxx;0,005 % XXXX XX 2; X373 (xxxx): 0,0005 % ≤ C &xx;&xxxx;0,005 % X&xxxx;= 1 X&xxxx;= 1“
„607-717-00-3	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxxxxxxxxxx-1-xx]-4-xxxxxxx-2X-1-xxxxxxxxxxxxxx-2-xx	—	104653-34-1	Xxxx. 1X Xxxxx Xxx. 1 Xxxxx Tox. 1 Acute Xxx. 1 XXXX XX 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410	XXX070	Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; H372 (xxxx): X ≥&xxxx;0,02 % XXXX XX 2; X373 (krev): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 100 X&xxxx;= 100“
„607-718-00-9	perfluornonan-1-ová xxxxxxxx [1] x&xxxx;xxxx xxxxx [2] x&xxxx;xxxxxx [3] xxxx	206-801-3 [1] [2] [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]	Xxxx. 2 Xxxx. 1B Lact. Acute Xxx. 4 Xxxxx Xxx. 4 STOT XX 1 Xxx Dam. 1	X351 X360Xx X362 X332 X302 X372 (játra, brzlík, xxxxxxx) X318	XXX08 XXX07 XXX05 Xxx	X351 X360Xx X362 X332 X302 X372 (xxxxx, brzlík, xxxxxxx) X318“
„607-719-00-4	xxxxxxxxxxxx-xxxxxx	201-545-9	84-61-7	Xxxx. 1X Xxxx Xxxx. 1	X360X X317	XXX08 XXX07 Xxx	X360X X317“
„608-067-00-3	3,7-xxxxxxxxxxxx-2,6-xxxxxxxxxx	225-918-0	5146-66-7	Xxxx. 1X	X340	XXX08 Xxx	X340“
„612-288-00-0	xxxxxxxxx (XXX); 5-xxxxx-2-xxxxxxxxxx-6-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxxxxxxxxx	255-391-2	41483-43-6	Xxxx. 2 Xxxx Sens. 1B Aquatic Xxxxxxx 1	X351 X317 X410	XXX08 XXX07 XXX09 Xxx	X351 X317 X410		X&xxxx;= 1“
„612-289-00-6	triflumizol (XXX); (1X)-X-[4-xxxxx-2-(xxxxxxxxxxxxxx)xxxxx]-1-(1X-xxxxxxxx-1-xx)-2-xxxxxxxxxxxxxxxx	—	68694-11-1	Xxxx. 1B Acute Xxx. 4 XXXX XX 2 Xxxx Xxxx. 1 Aquatic Xxxxx 1 Xxxxxxx Chronic 1	H360D H302 H373 (xxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X360X X302 X373 (xxxxx) X317 X410		X&xxxx;= 1 M = 1“
„616-218-00-X	xxxxxxxxxxxxxxxx (XXX); X-[9-(xxxxxxxxxxxxxxx)-1,2,3,4-xxxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx	—	1072957-71-1	Xxxxx Xxx. 3 Acute Xxx. 3 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X331 X301 X400 X410	XXX06 XXX09 Xxx	X331 X301 X410		X&xxxx;= 100 X&xxxx;= 100“
„616-219-00-5	xxxxxxxxx (ISO); N-{2-[3-chlor-5-(trifluormethyl)pyridin-2-yl]ethyl}-2-(trifluormethyl)benzamid	—	658066-35-4	Aquatic Xxxxxxx 2	X411	XXX09	X411“
„616-220-00-0	xxxxxxxxxx (ISO); 1-[(4-xxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxx-3-xxxxxxxxxxxxx	266-096-3	66063-05-6	Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 1 X&xxxx;= 1“
„617-023-00-2	xxxx-xxxxxxxxxxxxxxxxx	200-915-7	75-91-2	Xxxx. 2	H341	GHS08 Wng	H341“

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.